Search

Rena S Lapidus

from Pikesville, MD
Age ~60
Get Report
Also known as:
Rena G Lapidus, Rena S Gelerman, Ren Lapidus, Lapidus Ren
Phone and address:
7906 Ivy Ln, Baltimore, MD 21208
(410) 484-2538
Related to:
Brenda Lee Hall, 63Neil Lapidus, 74Elissa Croce, 34Robert MelsonPhilip H Tuttle, 84
Connected to:
Alissa C Lapidus, 56Cary S Lapidus, 68Gene M Lapidus, 70Jack R Lapidus, 56Jerry W Lapidus, 75Karen C Lapidus, 68Ronnie Lapidus, 66Rose C Lapidus, 81Bonnie L Lapier, 73Diane S Lapier, 61

Rena Lapidus Phones & Addresses

  • 7906 Ivy Ln, Pikesville, MD 21208 (410) 484-2538
  • 7906 Ivy Ave, Pikesville, MD 21208 (410) 484-2538
  • Baltimore, MD
  • Somerset, MA

Education

Degree: Graduate or professional degree

Resumes

Resumes

Rena Lapidus Photo 1

Assistant Director Shared Services

View page
Location:
7906 Ivy Ln, Pikesville, MD 21208
Industry:
Biotechnology
Work:
University of Maryland Marlene and Stewart Greenebaum Cancer Center
Assistant Director Shared Services
University of Maryland School of Medicine
Director, Translational Laboratory Shared Service ; Associate Professor
Eisai Feb 2008 - Jun 2009
Senior Scientist Ii
Mgi Pharma 2006 - 2008
Senior Scientist Ii
Guilford Pharmaceuticals 1997 - 2006
Scientist Ii
Education:
University of Maryland School of Medicine 1988 - 1993
Doctorates, Doctor of Philosophy, Philosophy, Pharmacology, Medicine Boston University 1984 - 1986
Bachelors, Bachelor of Arts, Chemistry Boston University 1984 - 1985
Skills:
In Vitro
In Vivo
Cancer
Cell
Drug Discovery
Oncology
Clinical Development
Pharmacology
Cell Biology
Assay Development
Biotechnology
Clinical Pharmacology
Clinical Trials
Drug Development
Toxicology
Cancer Research
Rena Lapidus Photo 2

Sr Scientist Ii At Mgi Pharma

View page
Position:
Sr Scientist II at MGI Pharma
Location:
Baltimore, Maryland Area
Industry:
Biotechnology
Work:
MGI Pharma
Sr Scientist II
Education:
Boston University 1984 - 1985

Publications

Us Patents

Pharmaceutical Compositions And Methods Of Inhibiting Angiogenesis Using Naaladase Inhibitors

View page
US Patent:
6395718, May 28, 2002
Filed:
Jul 6, 1998
Appl. No.:
09/110262
Inventors:
Barbara S. Slusher - Kingsville MD
Rena Lapidus - Pikesville MD
Assignee:
Guilford Pharmaceuticals Inc. - Baltimore MD
International Classification:
A61K 3166
US Classification:
514 75, 514 95, 514121, 514347, 514570, 514574
Abstract:
The present disclosure relates to a method of inhibiting angiogenesis comprising administering a N-Acetylated -Linked Acidic Dipeptidase (NAALADase) inhibitor to a patient in need thereof, and a pharmaceutical composition comprising an anti-angiogenic effective amount of a NAALADase inhibitor and a pharmaceutically acceptable carrier.

Naaladase Inhibitors Useful As Pharmaceutical Compounds And Compositions

View page
US Patent:
6458775, Oct 1, 2002
Filed:
Jul 2, 1999
Appl. No.:
09/346711
Inventors:
Paul F. Jackson - Bel Air MD
Keith M. Maclin - Baltimore MD
Eric Wang - Baltimore MD
Barbara S. Slusher - Kingsville MD
Rena S. Lapidus - Baltimore MD
Pavel Majer - Sykesville MD
Assignee:
Guilford Pharmaceutical Inc. - Baltimore MD
International Classification:
A61K 3166
US Classification:
514 75, 514143, 514277, 514574
Abstract:
The present invention relates to N-Acetylated -Linked Acidic Dipeptidase (NAALADase) inhibitors enzyme activity, pharmaceutical compositions comprising such inhibitors, and methods of their use to inhibit NAALADase enzyme activity, thereby effecting neuronal activities, inhibiting angiogenesis, and treating glutamate abnormalities, compulsive disorders, prostate diseases, pain and diabetic neuropathy.

Certain Compounds, Compositions And Methods

View page
US Patent:
8268800, Sep 18, 2012
Filed:
Oct 16, 2008
Appl. No.:
12/252961
Inventors:
Gregory S. Hamilton - Catonsville MD, US
Takashi Tsukamoto - Ellicott City MD, US
Dana V. Ferraris - Eldersburg MD, US
Bridget Duvall - Nottingham MD, US
Rena Lapidus - Baltimore MD, US
Assignee:
Eisai Inc. - Woodcliff Lake NJ
International Classification:
A01N 43/04
A61K 31/70
C07H 19/00
US Classification:
514 49, 514 50, 536 281, 536 284, 536 2853
Abstract:
The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Certain Compounds, Compositions And Methods

View page
US Patent:
8618075, Dec 31, 2013
Filed:
Jul 24, 2012
Appl. No.:
13/556404
Inventors:
Gregory S. Hamilton - Catonsville MD, US
Takashi Tsukamoto - Ellicott City MD, US
Dana V. Ferraris - Eldersburg MD, US
Bridget Duvall - Nottingham MD, US
Rena Lapidus - Baltimore MD, US
Assignee:
Eisai Inc. - Woodcliff Lake NJ
International Classification:
A01N 43/04
A61K 31/70
C07H 19/00
US Classification:
514 49, 514 50, 536 281, 536 284, 536 2853
Abstract:
The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Pharmaceutical Compositions And Methods Of Inhibiting Angiogenesis Using Naaladase Inhibitors

View page
US Patent:
20030064912, Apr 3, 2003
Filed:
Apr 11, 2002
Appl. No.:
10/119828
Inventors:
Barbara Slusher - Kingsville MD, US
Rena Lapidus - Pikesville MD, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
The present disclosure relates to a method of inhibiting angiogenesis comprising administering a N-Acetylated -Linked Acidic Dipeptidase (NAALADase) inhibitor to a patient in need thereof, and a pharmaceutical composition comprising an anti-angiogenic effective amount of a NAALADase inhibitor and a pharmaceutically acceptable carrier.

Naaladase Inhibitors Useful As Pharmaceutical Compounds And Compositions

View page
US Patent:
20030083374, May 1, 2003
Filed:
Jun 10, 2002
Appl. No.:
10/164553
Inventors:
Paul Jackson - Bel Air MD, US
Keith Maclin - Baltimore MD, US
Eric Wang - Baltimore MD, US
Barbara Slusher - Kingsville MD, US
Rena Lapidus - Baltimore MD, US
Pavel Majer - Sykesville MD, US
International Classification:
A61K031/21
C07C329/06
US Classification:
514/513000, 514/561000, 514/562000, 558/236000
Abstract:
The present invention relates to N-Acetylated -Linked Acidic Dipeptidase (NAALADase) inhibitors enzyme activity, pharmaceutical compositions comprising such inhibitors, and methods of their use to inhibit NAALADase enzyme activity, thereby effecting neuronal activities, inhibiting angiogenesis, and treating glutamate abnormalities, compulsive disorders, prostate diseases, pain and diabetic neuropathy.

Compositions For Treatment Of Prostate Cancers And Methods Of Making And Using The Same

View page
US Patent:
20030133903, Jul 17, 2003
Filed:
Jul 19, 2002
Appl. No.:
10/200040
Inventors:
Wenbin Dang - Belle Mead NJ, US
Rena Lapidus - Pikesville MD, US
William Vincek - Baltimore MD, US
International Classification:
A61K031/74
A61K031/337
US Classification:
424/078170, 514/449000
Abstract:
The present invention relates to compositions of a biocompatible polymer and an antineoplastic agent, and methods of using and making the same, for the treatment of prostate cancers. In certain embodiments, the polymer contains phosphorous linkages.

Use Of Naaladase Activity To Identify Prostate Cancer And Benign Prostatic Hyperplasia

View page
US Patent:
59812095, Nov 9, 1999
Filed:
Dec 4, 1997
Appl. No.:
8/985121
Inventors:
Barbara S. Slusher - Kingsville MD
Rena S. Lapidus - Baltimore MD
Assignee:
Guilford Pharmaceuticals Inc. - Baltimore MD
International Classification:
C12Q 137
C12Q 134
G01N 3353
US Classification:
435 23
Abstract:
The present invention relates to novel methods and kits for quantitating N-Acetylated. alpha. -Linked Acidic Dipeptidase (NAALADase) enzyme activity in biological samples, including prostate biopsies, seminal fluid, ejaculate, prostatic fluid, blood, saliva, and urine, for the purpose of identifying and differentiating between prostate carcinoma, benign prostatic hyperplasia, and normal prostate.
Control profile
Rena S Lapidus from Pikesville, MD, age ~60 Get Report